ScoreComparison
Why is Genscript Biotech Corp. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.66%
EBIT Growth (5y)
23.05%
EBIT to Interest (avg)
-55.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.37
Tax Ratio
4.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.71
EV to EBIT
16.59
EV to EBITDA
11.92
EV to Capital Employed
0.65
EV to Sales
4.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.93%
ROE (Latest)
-1.80%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(Q)
At HKD 3,437.57 MM has Grown at 1,233.05%
OPERATING CASH FLOW(Y)
Highest at HKD 3,212.51 MM
RAW MATERIAL COST(Y)
Fallen by -0.88% (YoY
-7What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -5.91 %
NET PROFIT(Q)
Lowest at HKD -733.01 MM
EPS(Q)
Lowest at HKD -1.83
Here's what is working for Genscript Biotech Corp.
Net Sales
At HKD 3,437.57 MM has Grown at 1,233.05%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (HKD MM)
Operating Cash Flow
Highest at HKD 3,212.51 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Raw Material Cost
Fallen by -0.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 305.32 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 305.32 MM has Grown at 12.29%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Genscript Biotech Corp.
Net Profit
At HKD -733.01 MM has Fallen at -646.29%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (HKD MM)
Net Profit
Lowest at HKD -733.01 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
EPS
Lowest at HKD -1.83
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
Debt-Equity Ratio
Highest at -5.91 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
